Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LB80380 vs Entecavir in Chronic Hepatitis B
NCT01026610Phase 2Completed
- Sponsor
- LG Chem
- Start
- Aug 2009
- Primary completion
- Nov 2010
- Modality
- Metabolically Activated Prodrugs
- Countries
- 2
01
Overview
A Phase 2 trial of besifovir dipivoxil maleate in Chronic Hepatitis B (CHB), sponsored by LG Chem. Started Aug 2009; status: completed.
02
Drugs
besifovir dipivoxil maleate
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT01026610.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01026610.